KLP Kapitalforvaltning AS Increases Position in Sabra Healthcare REIT, Inc. $SBRA

KLP Kapitalforvaltning AS lifted its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 7.4% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 49,500 shares of the real estate investment trust’s stock after buying an additional 3,400 shares during the period. KLP Kapitalforvaltning AS’s holdings in Sabra Healthcare REIT were worth $913,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the stock. Bank of New York Mellon Corp raised its holdings in shares of Sabra Healthcare REIT by 1.8% in the 1st quarter. Bank of New York Mellon Corp now owns 4,114,215 shares of the real estate investment trust’s stock worth $71,875,000 after purchasing an additional 74,564 shares during the period. Nuveen LLC bought a new stake in shares of Sabra Healthcare REIT in the 1st quarter worth approximately $61,791,000. Advisors Capital Management LLC raised its holdings in shares of Sabra Healthcare REIT by 20.5% in the 1st quarter. Advisors Capital Management LLC now owns 2,232,609 shares of the real estate investment trust’s stock worth $39,004,000 after purchasing an additional 380,505 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Sabra Healthcare REIT by 16.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,687,977 shares of the real estate investment trust’s stock worth $29,489,000 after purchasing an additional 243,274 shares during the period. Finally, Victory Capital Management Inc. raised its holdings in shares of Sabra Healthcare REIT by 12.7% in the 1st quarter. Victory Capital Management Inc. now owns 1,630,076 shares of the real estate investment trust’s stock worth $28,477,000 after purchasing an additional 183,739 shares during the period. Institutional investors own 99.40% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. BMO Capital Markets lifted their price target on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a “market perform” rating in a report on Monday, August 25th. Cantor Fitzgerald started coverage on shares of Sabra Healthcare REIT in a report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price target on the stock. Wells Fargo & Company boosted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a report on Wednesday, August 27th. Weiss Ratings reissued a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Wednesday, October 8th. Finally, Scotiabank boosted their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a “sector perform” rating in a report on Monday, June 23rd. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $20.71.

Sabra Healthcare REIT Trading Down 0.2%

Shares of SBRA stock opened at $17.60 on Thursday. The company’s fifty day simple moving average is $18.71 and its two-hundred day simple moving average is $18.17. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $20.03. The stock has a market capitalization of $4.22 billion, a price-to-earnings ratio of 23.16, a PEG ratio of 1.18 and a beta of 0.85.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.02. The firm had revenue of $189.15 million for the quarter, compared to analysts’ expectations of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.8%. Sabra Healthcare REIT’s dividend payout ratio is presently 157.89%.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.